Summit Global Investments - TONIX PHARMACEUTICALS HLDG C ownership

TONIX PHARMACEUTICALS HLDG C's ticker is and the CUSIP is 890260706. A total of 2 filers reported holding TONIX PHARMACEUTICALS HLDG C in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Summit Global Investments ownership history of TONIX PHARMACEUTICALS HLDG C
ValueSharesWeighting
Q1 2022$5,000
-28.6%
20,0000.0%0.00%
Q4 2021$7,000
-41.7%
20,0000.0%0.00%
-100.0%
Q3 2021$12,000
-45.5%
20,0000.0%0.00%0.0%
Q2 2021$22,000
-15.4%
20,0000.0%0.00%
-50.0%
Q1 2021$26,000
+85.7%
20,0000.0%0.00%
+100.0%
Q4 2020$14,000
-17.6%
20,0000.0%0.00%
-50.0%
Q3 2020$17,00020,0000.00%
Other shareholders

There were no reported owners of TONIX PHARMACEUTICALS HLDG C in Q2 2022.

NameSharesValueWeighting ↓
View complete list of TONIX PHARMACEUTICALS HLDG C shareholders